PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Clinical trial NCT07630363 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07630363
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma (RCC)PTC Atorvastatin Targeted Therapy Combined With Immunotherapy

Start date: 2026-05-14
Primary completion: 2028-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.